In this literature reappraisal, we summarize the instance studies and other epidemiological informations that examine disease badness and result of undulant fever in HIV coinfected persons. A Medline hunt was conducted to place instance studies and epidemiological analyses on HIV patients with the extra diagnosing of undulant fever infection. In entire, we identified 29 instances from 6 chief survey populations ( Belgium, Austria, Spain, Argentina, Kenya, and India ) that met these standards. We reviewed decisions from each study, identified research spreads, and attempted to discourse the immunology and pathology of undulant fever infection and why it seems undulant fever is non recognized as an timeserving infection in HIV patients. We conclude that public wellness workers would profit from unequivocal informations from larger, randomized controlled tests of undulant fever surveillance in HIV septic individuals, peculiarly in states where both undulant fever and HIV are prevailing. Although most surveies report similar clinical presentation and result in HIV-positive and HIV-negative patients, strict monitoring is indispensable to guarantee that if there are any inauspicious effects in HIV infected patients, they are rapidly identified and minimized.
Brucellosis, a bacterial infection caused by assorted species of Brucella ( the most infective species being B. melitensis and B. suis ) , is the most common zoonotic disease in the universe with more than 500,000 new instances happening yearly ( Pappas et al. , 2006 ) . Brucella species are facultative, Gram-negative, coccobacilli that are normally transmitted to worlds by either consuming unpasteurised milk or dairy merchandises from septic animate beings, or through scratchs of the tegument when managing infected animate beings ( Brunette, 2009 ) . Brucella species are besides extremely infective in the research lab via aerosolization, and therefore warrants biosafety level-3 safeguards.
The geographic distribution of human undulant fever is invariably altering with regard to switching public wellness and animate being control plans, debut of cultural or ritual slaughters, every bit good as socioeconomic position and political strife in endemic states ( Seleem et al. , 2009 ; Pappas et al. , 2006 ) . Furthermore, the rapid spread of world-wide globalisation and touristry increases the opportunity that a individual may come into contact with an septic animate being or consume unpasteurised milk merchandises thereby infecting themselves.
Developing states frequently lack pasteurisation Torahs, carnal control or slaughter ordinances, every bit good as complete undulant fever surveillance plans in order to forestall or supervise possible eruptions. Many of these states at the same time have widespread HIV epidemics. Other than little surveies and single instance studies, there have been no large-scale surveies in the literature that look at the immune response to undulant fever in HIV patients, or research that has determined the badness or result of undulant fever in HIV-infected individuals. Even fewer instance studies have been published for AIDS patients with undulant fever, hence, it is ill-defined how Brucella affects patients who are farther immunologically compromised. Surveies of HIV related infections have chiefly been concentrated in North America and Europe, where undulant fever is now a comparatively rare infection and few instances of undulant fever in HIV-positive patients have been reported. This reappraisal of the literature hopes to roll up a sum-up of all surveies refering undulant fever and HIV/AIDS and to clarify what subjects need to be studied farther.
INCIDENCE AND IMMUNE RESPONSE
Latest planetary estimations from 2008 show that 33.4 million people are populating with HIV/AIDS with 2.7 million people being freshly infected with HIV that twelvemonth ( UNAIDS/WHO, 2008 ) . Patients with HIV are known to be vulnerable to certain intracellular pathogens due to the profound damage of their B- and T-cell response. The pathogens that predominate in HIV septic individuals are normally referred to as timeserving infections ( OIs ) and are an of import cause of morbidity and mortality for HIV-infected individuals ( Brooks et al. , 2009 ) . By definition, OIs are caused by beings of low or no virulency which are non-pathogenic in persons with an integral immune system or are caused by known pathogens who present in a different than the usual manner in immunodeficient persons or in the signifier of increased virulency, return, multi-drug opposition or untypical presentation ( WHO, 1999 ) . Most OIs occur in HIV septic persons as the CD4 count diminutions, with a bulk presenting when the CD4 count reaches & A ; lt ; 200cells/µl ( Chitra et al. , 2009 ) . Both the clinical class of HIV and the form of OIs vary from patient to patient based on socioeconomic standing, degree of hygiene, entree to care, and besides in miscellaneous geographic parts ( Gautam et al. , 2009 ) . Regions that are bad for developing undulant fever include the Mediterranean Basin ( Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa ) , South and Central America, Eastern Europe, Asia, Africa, and the Middle East. Brucella are present in animate beings such as caprine animals, sheep, hogs, and cowss, and in wildlife. Brucellosis is an occupational disease among those working with septic farm animal, and can infect individuals who consume unpasteurised dairy merchandise and/or uncooked meat. Brucellosis is common in states that do non hold a standardized populace wellness system or undulant fever control plans for farm animal.
It seems sensible to surmise that HIV-infected patients may be more vulnerable to undulant fever, nevertheless, undulant fever has been described seldom in patients infected with HIV, despite the fact that obliteration of intracellular bacteriums are mostly dependent on cell-mediated unsusceptibility ( Moreno et al. , 1998 ) . In add-on, since Brucella infection is mostly dependent on the host immune response, it is sensible to see that HIV infected patients might be particularly prone to developing chronic or perennial signifiers of undulant fever in countries with a high prevalence of both infections ( Ibarra et al. , 2003 ) .
Although acute undulant fever induces both humoral and cell-mediated immune responses, merely cell-mediated unsusceptibility is necessary for obliteration of Brucella ( Pedro-Botet et al. , 1992 ) . Probes on the pathogenesis of undulant fever show that the Brucella can last in phagocytic cells, and cell-mediated unsusceptibility plays an of import function in unsusceptibility against bacteriums. Brucella organisms non merely defy killing by neutrophils following phagocytosis, but besides retroflex inside macrophages and nonprofessional scavenger cells. Additionally, endurance in macrophages, which is considered to be responsible for the constitution of chronic infections, enables bacteriums to get away the extracellular mechanisms of host defence such as complement activation and antibody reactions ( Dizer et al. , 2005 ) .
In a instance study published by Pedro-Botet et al. , research workers found that although the terrible depletion of CD4+ T-cells, one of the primary manifestations of HIV infection, may be a predisposing factor for undulant fever, the addition in the CD4+ T-cell count after recovery from undulant fever in their HIV+ instance patient suggests that the Brucella-HIV association may be strictly coinciding as the same observation has been described in non-compromised patients as good ( Pedro-Botet et al. , 1992 ) . Despite the fact that intracellular Brucellae are mostly dependent on cell-mediated unsusceptibility, HIV+ patients seem to hold comparatively preserved unsusceptibility after Brucella infection ( Pedro-Botet et al. , 1992 ) . This is comparable with the survey Moreno et Al. performed in1998, which showed that most instances of undulant fever occur in symptomless HIV patients who have comparatively preserved unsusceptibility. This is in contrast with the well-described association between HIV and tuberculosis- the proportion of patients with undulant fever who are coinfected with HIV seems to be low and non significantly different to that in HIV-negative individuals ( Pape et al. , 1993 ) . While undulant fever does non look to be immunologically associated with HIV infection, the significance of this deduction is still non understood.
PUBLISHED CASE REPORTS AND STUDIES
Reappraisal of the medical literature showed that really few instances of undulant fever in HIV-infected patients have been reported. In a serological survey performed by Paul et Al. in Nairobi, Kenya, research workers looked at sera from 100 persons ( 65 of whom were HIV-positive ) and tested them for Brucella-specific antibody. ( Brucella serology was done retrospectively on stored sera from patients from a old survey ) . Twenty-five per centum of HIV-positive and 14 % of HIV-negative patients had anti-Brucella IgG and 12 % of HIV-positive and 17 % of HIV-negative patient had anti-Brucella IgM, which shows comparatively high degrees of exposure in the survey population. Merely two HIV positive patients tested positive with antibody responses to Brucella comparable to those of immunocompetent persons and were subsequently confirmed to be infected with B. melitensis. Patient 1 and 2 did non demo clinical characteristics of terrible immunodeficiency ; the CD4+ count for patient 1 was 890×106/L, while the CD4+ count for patient 2 was non identified in the instance study. Due to the little sample size, nevertheless, the writers concluded that there was no important association between Brucella serology and HIV position ( Paul et al. , 1995 ) . They besides concluded that HIV infection does non look to impact the truth of anti-Brucella antibody sensing ( by ELISA ) , the clinical class of undulant fever, or the successful intervention of undulant fever.
In another survey performed in India by Sarguna et Al. ( 2002 ) , a undulant fever instance study was published for a 21-year old, HIV-positive male ( CD4+ count was non provided, nevertheless, entire lymph cell count was 7600/mm3 ) . A diagnosing of undulant fever was made after high agglutinin titres ( 640 ) were confirmed by the standard agglutination trial ( SAT ) . The patient responded good to a 6-week antibiotic intervention regimen of Achromycin and streptomycin. The writers noted that the presentation of this instance was typical and that the patient had comparatively preserved unsusceptibility. The writers of this paper likewise concluded that the epidemiology, clinical presentation, diagnosing, response to therapy and result are correspondent to those observed in non-HIV septic patients.
Similarly, the first instance study of a Brucella Canis infection in an HIV-positive patient was reported in 2009 ( Lucero et al. , 2009 ) . This patient presented with a feverish syndrome and had a CD4+ count of 385 cells/µl. The patient received antibiotic intervention ( doxycycline/ciprofloxacin ) and showed betterment every bit shortly as one hebdomad after originating therapy. No symptoms of backsliding were detected during the follow-up visit ( 22 months post diagnosing ) . The clinical class of this instance was similar to those shown in immunocompetent patients and HIV position was non deemed to play an incendiary function in infection, intervention or instance direction.
In 1992, Pedro-Botet et al. , described two instance patients and suggested that Brucella infection was coinciding in HIV-positive patients. One instance patient with a CD4+ count of 150×106/L, improved after 21 yearss of intervention with Vibramycin and Rifadin, nevertheless, the patient was lost to followup after being discharged from the infirmary. The 2nd HIV-positive patient ( CD4+ count of 172×106/L ) was prescribed Vibramycin and Rifadin and was said to hold recovered to the full in 30 yearss. The patient was monitored 6 months post-treatment and remained symptomless, with no backsliding of undulant fever, and no extra HIV-related complications. His CD4+ count 6 months post-treatment was besides significantly higher at 420×106/L. The writers concluded that the addition in T-cell count after recovery may propose that the Brucella-HIV association may be causal.
In a short instance study researching FDG-PET for usage as a tool to supervise chronic osteomyelitic undulant fever ( a rare complication of Brucella infection ) , Zaknun et Al. published images earlier intervention every bit good as 6 hebdomads following a multiple antibiotic regimen ( regimen was non specified ) . The instance patient was a 33-year old HIV patient with a CD4 count of 216 cells/µl. The image before showed important disease load, while the image taken after intervention showed a important decrease in disease load. However, the writers were unable to turn to whether or non this complication occurred due to HIV coinfection.
In another more complicated instance survey in Belgium, a 35-year old male with AIDS was admitted to the infirmary after an epileptic tantrum ( Galle et al. , 1997 ) . Six months before, he had undergone a encephalon biopsy which showed infection with toxoplasmosis. After intervention of both toxoplasmosis and HIV infection, his CD4 count remained & A ; lt ; 200 cells/µl. One month before the current ictus, the patient recalled going to Portugal where he consumed fresh caprine animal cheese ; he besides remembered exhibiting an influenza-like unwellness during his stay. Upon admittance to the infirmary, doctors resected the bone flap and took civilizations from an epidural abscess that had formed which yielded both Staphylococcus epidermidis and Brucella melitensis. The writers were diffident whether or non the postoperative lesion allowed for a secondary colonisation centre for the bacterium, or if the development of the abscess was entirely due to B. melitensis or S. epidermidis. However, three months after antibiotic intervention ( ) , the patient was symptomless with no complications and had non had a backsliding of undulant fever.
The largest epidemiological survey ( to day of the month ) that examined the relationship between HIV and undulant fever was reported by Moreno et Al. They included Spanish infirmaries in countries where undulant fever was endemic, yet, at the terminal of their survey, they reported a low rate of undulant fever in HIV-infected patients ( Moreno et al. , 1998 ) . Out of the 23 infirmaries sampled from 1981 to 1995, merely 12 HIV-infected patients in seven infirmaries were diagnosed with undulant fever. The writers concluded that HIV infection does non look to increase the incidence of undulant fever and that the clinical result is similar to those observed in non-HIV septic patients ( Moreno et al. , 1998 ) .
In a individual instance study published in 2000, Fernandez et Al. reported that clinical features, diagnosing, response to therapy and result of undulant fever in an HIV-positive patient appeared to be similar to that observed in HIV-negative patients. However, this instance patient did expose a backsliding rate that was higher than is usually found in immunocompetent hosts. This higher backsliding rate was mirrored in 2003 by Ibarra et Al. in a individual instance of get worsing undulant fever in an HIV-positive patient.
In 1992, Mart & A ; iacute ; n et Al. describe a instance of undulant fever in a 34 twelvemonth old who had been diagnosed with HIV 6 old ages prior. Upon diagnosing with undulant fever, CD4 was 570mm3. After a 45 twenty-four hours regimen of rifampicin and Vibramycin, the patient was clinically good and symptomless. At 6 months post intervention, the patient suffered a feverish backsliding and is treated with a 2nd class of combination therapy dwelling of streptomycin, Vibramycin and zidomidina.
While the clinical advancement was favourable, seven months of the patient being symptomless, a everyday blood civilization revealed continued infection with Brucella. At this clip, CD4 count was 228mm3. Doctors noted that the patient was presently in the center of a 3rd rhythm of intervention with Vibramycin and rifampicin at the clip of publication. Besides, the patient was reported to hold adequately followed intervention regimens and had left the environment in which he was originally infected ( hence, they believe possibility of re-infection is low ) . They concluded that co-infection with HIV allowed for easier backsliding of undulant fever, which raises jobs that are seen in other timeserving infections in HIV patients. The writers cite that co-infection with HIV may take to difficulty making curative intervention degree ( Martin, 1992 ) . As an intracellular bacteria, it may be more hard to handle in HIV patients which may ensue in more frequent returns. This raises other inquiries and shows the importance of the patient ‘s immune response to infection with Brucella
Recently, Abdollahi et Al. ( 2010 ) , performed a cross-sectional study of undulant fever serology in HIV infected patients and healthy controls. They found that positive undulant fever serology was significantly higher in HIV-infected patients than in controls ( 73.3 % vs. 30 % , severally, odds ratio 6.42, P & A ; lt ; 0.001 ) . It was besides higher in males than females, p=0.001. Brucellosis-infected patients had significantly lower haemoglobin and white blood cell counts compared with brucellosis-uninfected patients ( p & A ; lt ; 0.001 ) . In HIV-positive patients, white blood cell count was significantly lower in brucellosis-infected than brucellosis-uninfected patients ( p & A ; lt ; 0.05 ) . They concluded that undulant fever infection is an of import infection in HIV-infected patients. The intervention of undulant fever may be of great clinical importance in the direction of HIV infection in a undulant fever endemic state like Iran.
Lawaczeck et Al. 2010:
There has been an interesting correlativity between undulant fever rates in HIV-infected individuals.
There has been changing associations between undulant fever rates in HIV-infected individuals. Larger surveies would be helpful in finding the immunologic function of chronic undulant fever in both HIV- and non-HIV septic patients. Surveies that examined the function of backsliding vs. possible re-infection would be of involvement, every bit good as possible result differences in HIV vs. AIDS patients. Last, the visual aspect of extra OIs would be of involvement while analyzing the immunologic relationship within a subset of patients.
In countries of the universe where HIV rates are high ( sub-Saharan Africa, Middle East, Asia, etc. ) , there is besides frequently a deficiency of pasteurisation consciousness and therefore a high rate of undulant fever every bit good. Larger surveies that examined the aforesaid relationships between immune competency and undulant fever would raise the statistical significance of results versus single instance studies that are frequently published. If undulant fever is different from other bacterial infections, it would be of involvement to analyze what makes Brucella respond otherwise to the host immune system of an HIV-infected person. Other diseases like melioidosis are seldom reported within HIV-infected patients, nevertheless result may be disturbed.
Many of these states at the same time have widespread HIV epidemics. Other than little surveies and single instance studies, there have been no large-scale surveies in the literature that look at the immune response to undulant fever in HIV patients, or research that has determined the badness or result of undulant fever in HIV-infected individuals.
While current research shows that the epidemiology, clinical presentation, diagnosing, response to therapy, and result are similar to those observed in non-HIV septic patients ( Moreno et al, 1996 ) ,
In a missive to the editor in a 1983 issue of Irish Medical Journal, a physician makes a comparing between chronic undulant fever and AIDS, saying that the acquired immune suppression associated with chronic undulant fever appears to be similar to AIDS and that coumarin may be utile in intervention of both conditions ( Thornes, 1983 ) . Further research on this observation…
Probes on the pathogenesis of undulant fever show that the Brucella can last in phagocytic cells, and cell-mediated unsusceptibility plays an of import function in unsusceptibility against bacteriums. They studied whether supplementation of levamisole with conventional antibiotic therapy would better anergy against Brucella and concluded that it had no immunostimulating consequence on the footing of lymph cell subgroups ratios measured and the ability of phagocytosis. More larger clinical and laboratory tests aare necessary to look into the immunological and physiological effects of levamisole on TH1 subtyppes and cytokine secernment.
Probes on the pathogenesis of undulant fever show that the Brucella can last in phagocytic cells, and cell-mediated unsusceptibility plays an of import function in unsusceptibility against bacteriums. Brucella organisms non merely defy killing by neutrophils following phagocytosis, but besides retroflex inside macrophages and nonprofessional scavenger cells. Additionally, endurance in macrophages, which is considered to be responsible for the constitution of chronic infections, enables bacteriums to get away the extracellular mechanisms of host defence such as complement activation and antibody reactions.
Brucella can modulate host immune response, taking to T-cell anergy and chronic infection.
Few instances of undulant fever have been reported from persons infected with HIV, and the relationship between undulant fever and HIV infection remains mostly uninvestigated, likely because most surveies on HIV have been conducted in countries of the universe where undulant fever is now seldom diagnosed or where surveillance is missing.
While it seems sensible to surmise that HIV-infected patients are vulnerable to other intracellular pathogens, a reappraisal of the literature seems to bespeak that HIV infection does non look to significantly act upon the presentation or result of disease due to brucellosis. Despite the fact that OIs tend to do significant morbidity, necessitate toxic therapies, and shorten the endurance of people with HIV infection, HIV coinfection does non look to increase the incidence of undulant fever and does non look to be a major hazard factor for undulant fever ( Gauyam et al. , 2009 ) . However, more research is needed to farther describe: 1 ) the epidemiology of coincident HIV/Brucella infection, 2 ) the clinical features during coincident infection, 3 ) diagnostic response to therapy in immunocompromised patients, and 4 ) farther elucidate the result of undulant fever in patients infected with HIV ( Moreno et al. , 1996 ) .
Abdollahi A, Morteza A, Khalilzadeh O, Rasoulinejad M. Brucellosis serology in HIV-
septic patients. Int J Infect Dis. 2010 Aug 10. [ Epub in front of print ]
Brooks J, Kaplan J, Masur H. What ‘s New in the 2009 U.S. Guidelines for Prevention
and Treatment of Opportunistic Infections Amont Adults and Adolescents with HIV? Topics in HIV Medicine- International AIDS Society ( USA ) . 2009 ; 17 ( 3 ) :109-114.
Brunette, GW. 2009. CDC Health Information for International Travel ( 2010 ) : The
Yellow Book. Mosby Elsevier, Atlanta.
Chitra Y, Urgen S, Dayananda I, Brajachand S. Effect of Anti Retroviral Therapy ( ART )
on CD4 T Lymphocyte Count and the Spectrum of Opportunistic Infections in HIV/AIDS in Manipur. J Commun Dis 2009 ; 41 ( 1 ) : 19-24.
Dizer U, Hayat L, Beker CM, G & A ; ouml ; renek L, Ozguven V, Pahsa A. The consequence of the
doxycycline-rifampicin and levamisole combination on lymph cell subgroups and maps of phagocytic cells in patients with chronic undulant fever. Chemotherapy 2005 ; 51 ( 1 ) : 27-31.
Fernandez Reyes JL, Jimenez FR, Sanchez FB, Gutierrez Moreno JM. Acute undulant fever
and human immunodeficiency virus infection. An Med Interna. 2000 May ; 17 ( 5 ) :275.
Galle C, Struelens M, Liesnard C, Godfroid J, Maes N, Dewitte O, Farber C, Clevenbergh
Ph, Van Vooren J. Brucella melitensis Osteitis Following Craniotomy in a Patient with AIDS. Clin Infect Dis 1997 ; 24: 1012.
Gautam H, Bhalla P, Saini S, Uppal B, Kaur R, Braveja C, Dewan R. Epidemiology of
Opportunist Infections and Its Correlation with CD4 T-Lymphocyte Counts and Plasma Viral Load Among HIV-Positive patients at a Tertiary Care Hospital in India. J Int Assoc Physicians AIDS Care 2009 ;
Ibarra V, Blanco J, Metola L, Oteo J. Correspondence: Get worsing undulant fever in a patient
infected with the human immunodeficiency virus ( HIV ) . Clin Microbiol Infect 2003 ; 9:1259-1260.
Khatun M, Islam A, Baek B, Lee S. Characteristics of the immune response during ague
undulant fever in Sprague-Dawley rats. J Infect Dev Ctries 2009 ; 3 ( 5 ) :392-397.
Kilic S, Akbulut H, Ozden M, Bulut V. Gamma/delta T cells in patients with actue
undulant fever. Clin Exp Med 2009 ; 9 ( 2 ) :101-104.
Lawaczeck E, Toporek J, Cwikla J, Mathison A. Brucella Canis in a HIV-Infected
Patient. Zoonosiss and Public Health 2010. no. Department of the Interior: 10.1111/j.1863-2378.2010.01334.x
Lucero N, Maldonado P, Kaufman S, Escobar G, Boeri E, Jacob N. Brucella Canis
doing infection in an HIV-Infected Patient. Vector Borne Zoonotic Dis 2009 ; Sept 2 Short Communication.
Madkour MM. Madkour ‘s Brucellosis, 2nd erectile dysfunction. 2001: Springer, London.
Mart & A ; iacute ; n I, Ramos C, Guti & A ; eacute ; rrez A, Arazo P, Aguirre JM. Infecci & A ; oacute ; n por VIH y bruceloisis
chromium & A ; oacute ; nica. Enf. Infec. Y Microbiol. Clin. 1992 ; 10 ( 9 ) pg. 566-567.
Marcotty T, Matthys F, Godfroid J, Rigouts L, Ameni G, Gey van Pittius N, Kazwala R,
Muma J, Van Helden P, Walravens K, DeKlerk L, Geoghegan C, Mbotha D, Otte M, Amenu K, Abu Samra N, Botha C, Ekron M, Jenkins A, Jori F, Kriek N, McCrindle C, Michel A, Morar D, Roger F, Thys E, Van den Bossche P. Zoonotic TB and undulant fever in Africa: ignored zoonotic diseases or minor public-health issues? The results of a multi-disciplinary workship. Ann Trop Med Parasitol 2009 ; 103 ( 5 ) :401-411.
Moreno S, Ariza J, Espinosa F, Podzamczer D, Miro J, Rivero A, Rodriguez-Zapata M,
Arrizabalaga J, Mateos R, Herrero F. Brucellosis in patients infected with Human Immunodeficiency Virus. Eur J Clin Microbiol Infect Dis 1998 ; 17:319-326.
Moreno S, Espinosa F, Podzamczer D, Miro J, Arrizabalaga J, Mateos R, Rodriguez-
Zapata M, Ariza J, Herrero F. Brucellosis and HIV-infection.Abstr Intersci Conf Antimicrob Chemother Intersci Conf Antimicrob Agents Chemother 1996 ; Sept 15-18: 192 ( # 130 ) .
Oliveira S, de Oliveira F, Macedo G, de Almeida L, Carvalho N. The function of innate
immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond. Microbes Infect 2008 ; 10 ( 9 ) :1005-1009.
Pape J, Jean S, Ho J, Hafner A, Johnson W. Effect of INH prophylaxis on
incidence of active TB and patterned advance of HIV infection. Lancet. 1993 Jul ; 342 ( 8866 ) :268-72
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos E. The new planetary map of
human undulant fever. The Lancet 2006 ; 6: 91-99.
Pasquali P, Thornton A, Vendetti S, Pistoria C, Petrucci P, Tarantino M, Pesciaroli M,
Ruggeri F, Battistoni A, Shevach E. CD4+CD25+ T regulative cells limit effecter T cells and favor the patterned advance of undulant fever in BALB/c mice. Microbes Infect 2009 ; 1-8.
Paul J, Batchelor B, Ojoo J, Amir M, Selkon J. Serological responses to brucellosis in
HIV-seropositive patients. Trans R Soc Trop Med Hyg 1995 ; 89:228-230.
Pedro-Botet J, Coll J, Auguet T, Rubies-Prat J. Brucellosis and HIV infection: a causal
association? AIDS 1992 ; 6 ( 9 ) :1039-1040.
Rubio Gutierrez A, Portu Zapirain J, Zubizarreta Garcia J, Ayensa Dean C. Brucella
abortus meningitis in a patient with HIV infection. Med Clin 1992 ; 99 ( 17 ) :678.
Sarguna P, Biolikar A, Rao A, Mathur D. Brucellosis in Association with HIV Infection-
A Case Report. Indian J Med Microbiol 2002 ; 20 ( 4 ) :221-222.
Seleem M, Boyle S, Sriranganathan N. Brucellosis: A re-emerging zoonotic disease. Vet
Microbiol 2009 ; .
UNAIDS/WHO: Global Summary of the HIV/AIDS epidemic, Geneva: December 2008.
WHO. 2006. Brucellosis in worlds and animate beings. WHO/CDS/EPR/2006.7.
WHO. 1999. HIV-Opportunistic Infections- Guidelines for readying of criterion
operating processs for laboratory diagnosing, WHO in coaction with Centre for Training on HIV/AIDS, clinical Management and guidance, Thailand.
Zaknun J, Zangerle R, Gabriel M, Virgolini I. FDG-PET for supervising disease activity
in an HIV-1 positive patient with disseminated chronic osteomyelitic undulant fever due to Brucella melitensis. Eur J Nucl Mol Imaging 2005 ; 32: 630.